PROCEPT BioRobotics CTO sells 373 shares at $20.95

EVP and CTO Barry L. Templin reported a small tax-related sale of PRCT shares linked to RSU vesting, leaving him with 94,826 directly held shares.

Rhea-AI Filing Summary

PROCEPT BioRobotics Corp (PRCT) reported that executive vice president and chief technology officer Barry L. Templin sold 373 shares of common stock on September 9, 2026 at $20.95 per share. According to the company, the sale was made under its sell-to-cover process to satisfy tax withholding on restricted stock units that vested on September 5, 2026. Following this tax-related sale, Templin directly holds 94,826 shares of PROCEPT BioRobotics common stock.

Insider Trade Summary

Net Seller: 373 shares

Net Sell 1 txn

Insider Templin Barry L

Role EVP, Chief Technology Officer

Sold 373 shs ($8K)

Type	Security	Shares	Price	Value
Sale	Common Stock F1	373	$20.953	$8K

Holdings After Transaction: Common Stock — 94,826 shares (Direct)

Footnotes (1)

1. F1. The shares were sold by the reporting person pursuant to the Issuer's sell-to-cover process for tax withholding obligations in connection with the vesting of the Restricted Stock Units on September 5, 2026.

Key Figures

Shares sold: 373 shares Sale price per share: $20.95 per share Shares held after transaction: 94,826 shares +1 more

4 metrics

Shares sold 373 shares Common stock sold on September 9, 2026

Sale price per share $20.95 per share Average price for the 373 shares sold on September 9, 2026

Shares held after transaction 94,826 shares Direct common stock holdings of Barry L. Templin after the sale

RSU vesting date September 5, 2026 Restricted Stock Units whose vesting triggered tax withholding

Key Terms

sell-to-cover process, tax withholding obligations, Restricted Stock Units

3 terms

sell-to-cover process financial

"sold by the reporting person pursuant to the Issuer's sell-to-cover process"

tax withholding obligations financial

"process for tax withholding obligations in connection with the vesting"

Restricted Stock Units financial

"in connection with the vesting of the Restricted Stock Units"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

FAQ

What insider transaction did PROCEPT BioRobotics (PRCT) report for Barry L. Templin?

Barry L. Templin reported selling 373 shares of PROCEPT BioRobotics common stock on September 9, 2026, in a transaction described as part of the company’s sell-to-cover process for tax withholding tied to vesting restricted stock units.

At what price were the PRCT shares sold in Barry L. Templin’s Form 4 filing?

The filing reports that 373 shares of PROCEPT BioRobotics common stock were sold at an average price of about $20.95 per share on September 9, 2026, as part of a tax-related sell-to-cover transaction.

How many PRCT shares does Barry L. Templin hold after the reported transaction?

After the September 9, 2026 transaction, Barry L. Templin directly holds 94,826 shares of PROCEPT BioRobotics common stock, as stated in the Form 4 filing.

Was Barry L. Templin’s PRCT share sale a discretionary sale or for tax withholding?

The Form 4 footnote states the 373-share sale was made under PROCEPT BioRobotics’ sell-to-cover process for tax withholding obligations related to restricted stock units that vested on September 5, 2026, indicating a tax-driven transaction.

Does the PRCT Form 4 indicate a Rule 10b5-1 trading plan for this transaction?

The filing’s Rule 10b5-1 checkbox is not marked as affirming a trading plan, and the footnote describes the sale as part of a sell-to-cover tax withholding process rather than a discretionary Rule 10b5-1 trading plan.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/10/2026 - 04:44 PM Accepted by SEC EDGAR 09/10/2026 - 04:44 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Templin Barry L

(Last) (First) (Middle)

150 BAYTECH DR.

(Street)

SAN JOSE CALIFORNIA 95134

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
PROCEPT BioRobotics Corp [ PRCT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP, Chief Technology Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/09/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/09/2026		S(1)		373	D	$20.953	94,826	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The shares were sold by the reporting person pursuant to the Issuer's sell-to-cover process for tax withholding obligations in connection with the vesting of the Restricted Stock Units on September 5, 2026.

Remarks:

	/s/ Jonathan Stone, Attorney-in-Fact for Barry Templin	09/10/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)